Low-grade gliomas in adults.

Area of Science:

• Neuro-oncology
• Neurosurgery
• Molecular Biology

Background:

• Low-grade gliomas (LGGs) are primary brain tumors with complex biology.
• Historically, treatment paradigms for LGGs have evolved slowly.
• Recent breakthroughs necessitate a review of current understanding and management.

Purpose of the Study:

• To provide a comprehensive review of recent advancements in low-grade glioma (LGG) research and clinical practice.
• To synthesize current literature on molecular markers, diagnostic imaging, surgical techniques, and adjuvant therapies for LGGs.
• To highlight the impact of these developments on patient outcomes in the modern neurosurgical era.

Main Methods:

• Systematic literature review of recent publications on low-grade gliomas.
• Analysis of studies focusing on molecular markers, advanced imaging techniques, surgical technologies, and adjuvant treatments.
• Synthesis of findings to provide an overview of the current neurosurgical management of LGGs.

Main Results:

• Significant progress has been made in understanding LGG molecular pathology.
• Innovations in diagnostic imaging and operative technologies are enhancing surgical precision.
• Novel adjuvant therapies are showing promise in improving patient survival and quality of life.

Conclusions:

• The integration of molecular insights, advanced imaging, and refined surgical techniques is transforming LGG management.
• These collective advancements offer improved prognoses and quality of life for patients with low-grade gliomas.
• Continued research and application of these modern approaches are crucial for optimizing patient care.